Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Hanley

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Cytotherapy|June 5, 2026
Overcoming five main challenges to targeting hematologic malignanciesMegha Thakkar, Patrick J Hanley, Alexey Bersenev, et al.
Journal of Visualized Experiments : Jove|May 17, 2012
Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirusPatrick J Hanley, Sharon Lam, Elizabeth J Shpall, et al.
British Journal of Haematology|April 11, 2016
Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphomaMatthew J Barth, Yaya Chu, Patrick J Hanley, et al.
Cytotherapy|April 2, 2019
Critical testing and parameters for consideration when manufacturing and evaluating tumor-associated antigen-specific T cellsJay G Tanna, Robert Ulrey, Kirsten M Williams, et al.
Current Hematologic Malignancy Reports|October 24, 2019
Driving the CAR to the Bone Marrow Transplant ProgramHema Dave, Lauren Jerkins, Patrick J Hanley, et al.
Frontiers in Cellular and Infection Microbiology|August 11, 2020
Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell TransplantationPing-Hsien Lee, Michael D Keller, Patrick J Hanley, et al.
Cytotherapy|September 8, 2010
Improving clinical outcomes using adoptively transferred immune cells from umbilical cord bloodPatrick J Hanley, Conrad Russell Cruz, Elizabeth J Shpall, et al.
Cytotherapy|April 24, 2017
Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experienceLaurie S Conklin, Patrick J Hanley, Jacques Galipeau, et al.
Scientific Reports|May 17, 2016
A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapyGuillaume Spielmann, Catherine M Bollard, Hawley Kunz, et al.
Exercise and Sport Sciences Reviews|April 19, 2017
Mobilizing Immune Cells With Exercise for Cancer ImmunotherapyRichard J Simpson, Austin B Bigley, Nadia Agha, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Cytotherapy|June 5, 2026
Overcoming five main challenges to targeting hematologic malignanciesMegha Thakkar, Patrick J Hanley, Alexey Bersenev, et al.
Journal of Visualized Experiments : Jove|May 17, 2012
Expanding cytotoxic T lymphocytes from umbilical cord blood that target cytomegalovirus, Epstein-Barr virus, and adenovirusPatrick J Hanley, Sharon Lam, Elizabeth J Shpall, et al.
British Journal of Haematology|April 11, 2016
Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphomaMatthew J Barth, Yaya Chu, Patrick J Hanley, et al.
Cytotherapy|April 2, 2019
Critical testing and parameters for consideration when manufacturing and evaluating tumor-associated antigen-specific T cellsJay G Tanna, Robert Ulrey, Kirsten M Williams, et al.
Current Hematologic Malignancy Reports|October 24, 2019
Driving the CAR to the Bone Marrow Transplant ProgramHema Dave, Lauren Jerkins, Patrick J Hanley, et al.
Frontiers in Cellular and Infection Microbiology|August 11, 2020
Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell TransplantationPing-Hsien Lee, Michael D Keller, Patrick J Hanley, et al.
Cytotherapy|September 8, 2010
Improving clinical outcomes using adoptively transferred immune cells from umbilical cord bloodPatrick J Hanley, Conrad Russell Cruz, Elizabeth J Shpall, et al.
Cytotherapy|April 24, 2017
Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experienceLaurie S Conklin, Patrick J Hanley, Jacques Galipeau, et al.
Scientific Reports|May 17, 2016
A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapyGuillaume Spielmann, Catherine M Bollard, Hawley Kunz, et al.
Exercise and Sport Sciences Reviews|April 19, 2017
Mobilizing Immune Cells With Exercise for Cancer ImmunotherapyRichard J Simpson, Austin B Bigley, Nadia Agha, et al.
Pageof 10